Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease
Gastroenterology Review · 2026 · 21 (1) · 82-87
DOI: 10.5114/pg.2026.160534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Review, 2026. Verfasst von Doaa Abdou Header und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Gastroenterology Unit, Faculty of Medicine, Alexandria University, Egypt. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Department, Gastroenterology Unit, Faculty of Medicine, Alexandria University, Egypt.
- Department of Medical Biochemistry, Faculty of Medicine, Alexandria University, Egypt.
Zitieren
APA
Header, D. A., Ali Ibrahim, A. M., Ramadan, A. M., Dwedar, F. I., & Aty, K. A. (2026). Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease. Gastroenterology Review, 21(1), 82-87. https://doi.org/10.5114/pg.2026.160534
Vancouver
Header DA, Ali Ibrahim AM, Ramadan AM, Dwedar FI, Aty KA. Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease. Gastroenterology Review. 2026;21(1):82-87. doi:10.5114/pg.2026.160534
BibTeX
@article{Header2026,
author = {Header, Doaa Abdou and Ali Ibrahim, Abeer Mahmoud and Ramadan, Asmaa Mahdy and Dwedar, Fatma Ibrahim and Aty, Khaled Abdel},
title = {Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease},
journal = {Gastroenterology Review},
year = {2026},
volume = {21},
number = {1},
pages = {82--87},
doi = {10.5114/pg.2026.160534}
}
EUVIMED